ATP1A3-Associated Paroxysmal Dystonia
Author Information
Author(s): Ledoux Mark S. MD, PhD, FANA
Primary Institution: Veracity Neuroscience LLC, Memphis, Tennessee, USA
Hypothesis
ATP1A3 mutations are associated with a diverse set of distinct neurological syndromes and intermediate phenotypes.
Conclusion
The study highlights the importance of recognizing ATP1A3 mutations in patients with paroxysmal non-epileptic neurological events.
Supporting Evidence
- ATP1A3 mutations are linked to various neurological syndromes.
- The patient experienced recurrent episodes of paroxysmal dyskinesias.
- Oxcarbazepine and clonazepam reduced the frequency of paroxysmal episodes.
Takeaway
This study is about a woman with a rare genetic mutation that causes her to have sudden movement problems, and some medicines helped her feel better.
Methodology
The case report includes video and clinical documentation of the patient's symptoms and genetic testing results.
Limitations
The study is based on a single case report, limiting the generalizability of the findings.
Participant Demographics
A 36-year-old right-handed female with a history of developmental delay and neurological issues.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website